Ad is loading...

FRTX

AS OF

Nov 15 closing price

Price

$0.71

Change

-$0.00 (-0.00%)

Capitalization

4.26M

Earnings call today

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

FRTX Stock FRTX is expected to report earnings to fall -572% to -151 cents per share on March 20

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

FRTX - Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc. Earnings Graph

Q4'23

Est.

$-1.51

Q3'23

Beat

by $0.92

Q2'23

Beat

by $1.29

Q1'23

Beat

by $0.51

Q4'22

Missed

by $0.07

The last earnings report on September 30 showed earnings per share of 32 cents, beating the estimate of -60 cents. P/B Ratio (0.429) is normal, around the industry mean (14.849). P/E Ratio (0.000) is within average values for comparable stocks, (95.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). FRTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.480) is also within normal values, averaging (211.128). With 540 shares outstanding, the current market capitalization sits at 4.26M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2000 Central Avenue

Phone

+1 720 505-4755

Employees

Web

https://www.frtx.com